Lucira Health, Inc., a medical technology company, focuses on the development and commercialization of infectious disease test kits. It develops a testing platform that produces molecular testing services. The company offers LUCIRA COVID-19 All-In-One Test Kit, a COVID-19 test kit; and develops influenza A and B viruses test kits. It has a patent license agreement with Eiken Ch...Show More
peer of
competitor of
Metrics
marketSTOCKS
msh_idCOM:LUCIRAHEALTH
localeus
websitehttps://www.lucirahealth.com
ipo_date2021-02-04
primary_stock_msh_idNASDAQ:LHDX
source_ref831a2387-4be9-4c19-b979-2b7c0916b503
products_or_servicesAt-home molecular diagnostic tests for infectious diseases, including COVID-19, influenza, and respiratory syncytial virus (RSV)